Teslio

The Corporation has approved the U.S. Food and Drug Administration (FDA) on a property based on a new drug for the treatment of symptoms of estrogen kinetic medium - to severe related to menopause as well as the prevention of osteoporosis, which is common among women in menopause. The pharmacological properties DUAVEE first pharmaceutical drug that combines estrogen - pharmacological inhibitor drug and catalyst for estrogen.Lean And Lovely Program

- which reduces the risk of uterine hyperplasia, which increases the likelihood of injury associated with malignant pharmaceutical drugs that are composed of estrogen.
According to the foundation property pharmacological compound of estrogen and given only for women in post-menopausal women who have not undergone a hysterectomy.http://health.reviewship.com/category/weight-loss/
Doctors advised the institution as a new pharmaceutical drug for short periods commensurate with the goals of treatment and the potential risks, it is possible to describe the new drug to prevent osteoporosis, and the ladies who increases the risk of losing the bone mass. The clinical trials that common side effects of the drug medication was cramp muscles, nausea, diarrhea, dyspepsia, abdominal pain, throat pain, throat and neck pain. Recommended by giving the drug at a rate of pharmacological one tablet a day with him and will be appended to fund warnings similar to the warnings that appear on the labels of drugs that contain estrogen.